– Sec Filing
Why Are Argenx Shares Trading Higher Today?
Argenx SE (NASDAQ: ARGX) reported topline results from the ADHERE study evaluating Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with chronic inflammatory
Related Posts
Redburn Partners Initiates Coverage On Estee Lauder Cos with Sell Rating, Announces Price Target of $210
Redburn Partners analyst Christopher Pitcher initiates coverage on Estee Lauder Cos (NYSE:EL) with a Sell rating and announces Price Target of $210.
What’s Going On With Google Parent Alphabet Stock Friday?
Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) Google stock is trading higher Friday amid reports of co-founder Sergey Brin increasing his involvement in the tech giant's
Shakeup At OpenAI: Sam Altman Returns As CEO, Microsoft Secures Board Observer Role
While Microsoft doesn't have any official voting power, its new role will grant the company enhanced visibility into the workings of this AI startup.